
Pexti 37.5mg Tablet CR
Marketer
Salas Pharmaceuticals
Salt Composition
Paroxetine (37.5mg)
Overview Pexti 37.5mg Tablet CR
Sertraline 37.5mg extended-release tablets are a selective serotonin reuptake inhibitor (SSRI) antidepressant commonly used to manage depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks. This medication improves mood and alleviates anxiety and tension, aiding recovery from depressive episodes for many patients. It can be administered with or without food. Dosage and frequency are determined by your physician to optimize symptom control, often beginning with a lower dose gradually increased. Never alter your dosage or discontinue use without consulting your doctor; abrupt cessation may worsen your condition or trigger unpleasant withdrawal symptoms (e.g., anxiety, restlessness, rapid heartbeat, dizziness, sleep disturbances). For maximum effectiveness, take this medication consistently at the same time daily; morning administration may be recommended if sleep is affected. Significant improvement may take several weeks. Report a lack of progress after four weeks. Common side effects include nausea, tiredness, dry mouth, decreased appetite, increased perspiration, lightheadedness, nervousness, trembling, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately report any sudden mood deterioration or suicidal thoughts. Before starting treatment, inform your doctor of any epilepsy, diabetes, liver or kidney disease, cardiovascular issues, or glaucoma, as these conditions may influence treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Interactions may occur with other medications, particularly other antidepressants and MAO inhibitors. Always disclose all medications you are currently taking to ensure your safety.
Primary Ingredients of Pexti 37.5mg Tablet CR
There is no text provided to rephrase.
Uses of Pexti 37.5mg Tablet CR
Managing depressive disorders | Addressing panic attacks and panic disorder | Anxiety disorder care and treatment
Major Benefits of Pexti 37.5mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pexti 37.5mg Controlled-Release tablet whole; do not damage it by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Pexti 37.5mg Tablet CR:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Pexti 37.5mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pexti 37.5mg Tablet CR whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
How Pexti 37.5mg Tablet CR works:
Serotonin levels in the brain are boosted by the extended-release Pexti 37.5mg tablet, a selective serotonin reuptake inhibitor (SSRI) used to treat depression. This mechanism alleviates depressive symptoms, both emotional and physical, and provides relief from anxiety, panic disorder, and obsessive-compulsive disorder.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pexti 37.5mg Tablet CR and alcohol is unsafe.
PregnancyUNSAFE
The extended-release Pexti 37.5mg tablet is contraindicated in pregnancy. Pregnant women should consult their physician; research in animal models and human studies indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Pexti 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Pexti 37.5mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these side effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, the use of Pexti 37.5mg Controlled-Release tablets requires careful monitoring. A modified dosage of Pexti 37.5mg CR tablets may be necessary. Medical advice should be sought.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Pexti 37.5mg Controlled-Release tablets. A modified dosage of Pexti 37.5mg Controlled-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Pexti 37.5mg Tablet CR :
Forgetting a Pexti 37.5mg CR tablet? Take it immediately if you remember. But if your next dose is nearly due, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Pexti 37.5mg Tablet CR
| Label | Value |
|---|---|
| Chemical Type | Piperidine Phenyl Derivative |
| Developing Good Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Actions | Selective serotonin reuptake inhibitors (SSRIs) |
